Validation of Heart Rate Monitors in Overweight and Obese Young Adults

NCT07184177 | Not Yet Recruiting DMC

• 1 other identifier: Validation Heart Rate Monitors
• Study Type: observational
• Target: 52
• Locations: 0 countries
• Sites: N/A

Brief Summary

Overweight and obesity are defined as an excessive accumulation of body fat that affects health. According to data from the World Health Organization (WHO), in 2022, there were 2.5 billion adults aged 18 years and older who were overweight, of whom 890 million were obese. In other words, 43% of adults aged 18 years and older were overweight, and 16% of them were obese. Overweight and obesity are key risk factors for various chronic diseases such as diabetes, hypertension, cardiovascular disease, and even some types of cancer. There is evidence that mortality from cardiovascular disease, and the incidence of cancer and diabetes, varies according to the amount of physical activity. In the context of high levels of sedentary time, higher levels of moderate to vigorous physical activity are recommended. There are various ways to treat overweight and obesity, the main ones usually being lifestyle changes, such as following a healthy diet and regular physical activity, as well as following pharmacological treatments. In this project, the focus will be on the fat metabolism generated during moderate physical activity. There are physical activity interventions aimed at increasing fat metabolism that may potentially reduce the symptoms of metabolic diseases such as obesity and type 2 diabetes. For this purpose, it is important to understand the factors that increase or decrease fat oxidation. Factors such as exercise intensity and duration are important to understand when determining maximum fat oxidation (FatMax). The aim is to develop comprehensive research that will generate knowledge and evidence on health issues with social impact through the evaluation of commercial technologies and innovative actions that promote the prevention, treatment, and resolution of national health problems such as obesity.

Conditions

Obesity &Amp; Overweight

Outcome Measures

Primary Outcomes (2)

• Heart rate at maximal fat oxidation

  Gas exchange and heart rate will be recorded throughout the exercise tests, while the rate of perceived exertion will be registered at the end of each stage using the modified Borg scale with a 0-10 rating. The average VO2 and VCO2 values of the last 2 min of each stage before RER ≥ 1.0 will be used to calculate fat and carbohydrate oxidation using the stoichiometric equations of Jeukendrup and Wallis. The maximum rate of fat oxidation and its corresponding intensity during exercise will be determined by mathematical modeling of fat oxidation kinetics, plotted against oxygen consumption (% VO2max). The symmetry, amplitude, and translation parameters of the curve will be calculated as well to represent the oxidative capacity of each subject.

  30 minutes

• Resting heart rate

  Resting heart rate of participants using 10 different heart rate monitors

  30 minutes

Study Arms (1)

Validation group

Participants to validate 10 heart rate monitors against electrocardiogram at resting and exercise at a maximal fat oxidation rate

Eligibility Criteria

• Age: 18 Years - 25 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)
• Sampling Method: Probability Sample

Study Population

Sedentary young adults aged between 18 and 35 years, all of whom will have a body mass index (BMI) ≥ 25 kg/m2. Participants will be recruited through snowball sampling.

You may qualify if:

• Body mass index ≥ 25 kg/m2
• Energy expenditure \< 600 METs a week
• Acceptance of informed consent

You may not qualify if:

• ≥100 mL of alcohol consumption per week
• Have limitations to perform regular physical activity
• Have a chronic non-communicable disease
• Answer "yes" to any of the questions on the Physical Activity Readiness-Questionnaire for Everyone (PAR-Q+), which represents a health risk.

Sponsors & Collaborators

• Universidad Autonoma de Baja California: lead

Related Publications (3)

• Chavez-Guevara IA, Amaro-Gahete FJ, Ramos-Jimenez A, Brun JF. Toward Exercise Guidelines for Optimizing Fat Oxidation During Exercise in Obesity: A Systematic Review and Meta-Regression. Sports Med. 2023 Dec;53(12):2399-2416. doi: 10.1007/s40279-023-01897-y. Epub 2023 Aug 16.

  PMID: 37584843 BACKGROUND

• Hernandez-Lepe MA, Hernandez-Ontiveros DA, Chavez-Guevara IA, Ramos-Jimenez A, Hernandez-Torres RP, Lopez-Fregoso RJ, Ramos-Lopez O, Amaro-Gahete FJ, Muniz-Salazar R, Olivas-Aguirre FJ. Impact of Exercise Training at Maximal Fat Oxidation Intensity on Metabolic and Epigenetic Parameters in Patients with Overweight and Obesity: Study Protocol of a Randomized Controlled Trial. J Funct Morphol Kinesiol. 2024 Oct 31;9(4):214. doi: 10.3390/jfmk9040214.

  PMID: 39584867 BACKGROUND

• Chavez-Guevara IA, Urquidez-Romero R, Perez-Leon JA, Gonzalez-Rodriguez E, Moreno-Brito V, Ramos-Jimenez A. Chronic Effect of Fatmax Training on Body Weight, Fat Mass, and Cardiorespiratory Fitness in Obese Subjects: A Meta-Analysis of Randomized Clinical Trials. Int J Environ Res Public Health. 2020 Oct 28;17(21):7888. doi: 10.3390/ijerph17217888.

  PMID: 33126461 BACKGROUND

MeSH Terms

Conditions

Obesity; Overweight

Condition Hierarchy (Ancestors)

Overnutrition; Nutrition Disorders; Nutritional and Metabolic Diseases; Body Weight; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Central Study Contacts

Francisco J Olivas Aguirre, PhD

CONTACT

+52 (656) 3058685; francisco.j.olivas@gmail.com

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Target Duration: 1 Day
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Full Time Professor

Study Record Dates

• First Submitted: September 13, 2025
• First Posted: September 19, 2025
• Study Start: January 19, 2026
• Primary Completion (Estimated): June 5, 2026
• Study Completion (Estimated): December 4, 2026
• Last Updated: September 19, 2025

Record last verified: 2025-09

Data Sharing

• IPD Sharing: Will share